Yuhui Chen
About Yuhui Chen
Yuhui Chen is a Scientist II with expertise in cancer immunology and virology, focusing on receptor and signaling pathways during virus infections and immune T cell targeting of tumors. Chen has held various research positions, including postdoctoral roles at Texas Children's Hospital and UNC Lineberger Comprehensive Cancer Center, and currently works at Precision BioSciences, Inc.
Work at Precision BioSciences
Yuhui Chen has been employed at Precision BioSciences, Inc. since 2021, currently holding the position of Scientist II. Prior to this role, Chen worked as a Scientist at the same company from 2019 to 2021. During this time, Chen contributed to various projects focused on developing innovative therapies, particularly in the realm of cell therapies for autoimmune diseases. The work at Precision BioSciences is situated in the Raleigh-Durham-Chapel Hill area, a hub for biotechnology and life sciences.
Education and Expertise
Yuhui Chen earned a Bachelor of Science in Bioengineering from South China University of Technology, completing the program from 2004 to 2008. Following this, Chen pursued a Doctor of Philosophy in Microbiology, General, at the same institution, achieving the degree from 2008 to 2013. Chen's academic background provides a strong foundation in both engineering principles and microbiological sciences. This education supports expertise in developing cell therapies, particularly for autoimmune diseases.
Background
Yuhui Chen's professional journey includes significant postdoctoral research experience. Chen worked as a Postdoctoral Associate at Texas Children's Hospital in the Feign Center from 2014 to 2015. Following this, Chen spent four years at the UNC Lineberger Comprehensive Cancer Center from 2015 to 2019. During these postdoctoral positions, Chen focused on receptor and signaling pathways during virus infections and the immune targeting of tumors, contributing to advancements in cancer immunology and virology.
Research Focus and Achievements
Yuhui Chen's Ph.D. research concentrated on the mechanisms of receptor and signaling pathways in the context of virus infections and immune T cell targeting of tumors. This research is critical for understanding how to enhance immune responses against cancer. Additionally, during postdoctoral research, Chen worked on cell therapy projects aimed at treating lymphoma, leukemia, and solid tumors, contributing to the development of targeted therapies in oncology.
Professional Experience in Cancer Immunology
Yuhui Chen has developed a strong background in cancer immunology and virology through various roles in research and development. The expertise gained through postdoctoral positions and current work at Precision BioSciences reflects a commitment to advancing therapeutic approaches for cancer treatment. Chen's work is particularly focused on leveraging immune mechanisms to combat malignancies, which is a significant area of research in modern oncology.